SB 6342
In CommitteeSenate
Seizure detection devices
Requiring coverage for seizure detection devices as durable medical equipment under certain circumstances.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill expands Washington’s Medicaid (medical assistance) program to cover seizure detection devices as durable medical equipment for eligible individuals, along with related services and subscriptions. It also adds new coverage requirements for preventive services like colorectal cancer screening, depression screening for youth and mothers, and child mental health assessments — all contingent on available funding. Additionally, it modifies hospital billing rules for patients who remain in the hospital after meeting discharge criteria due to lack of post-acute placement.
- Effective January 1, 2026, requires medical assistance (Medicaid) to cover seizure detection devices as durable medical equipment if deemed medically appropriate by a health care provider.
- Coverage includes full cost of the device and any related subscription or service (e.g., remote monitoring), reimbursed at 100% of the telemonitoring rate.
- Requires biennial review and updates to the list of covered devices to ensure access to FDA-approved technologies.
- Expands coverage for noninvasive colorectal cancer screening tests (e.g., stool-based tests) and follow-up colonoscopies if positive, effective January 1, 2024.
- Requires coverage for depression screening for youth ages 12–18 and maternal depression screening for mothers of children up to 6 months old, subject to funding.
- Requires coverage for mental health assessment and diagnosis for children ages birth–5, including up to five sessions for intake/assessment and use of the DC:0-5 diagnostic system.
Who is affected
- People with epilepsy or other conditions causing seizures — Individuals with seizure disorders (including children and adults) who may qualify for coverage of FDA-approved seizure detection devices to help prevent injury or death during seizures and support clinical care.
- Caregivers and family members — Families and caregivers of individuals with seizures, who may receive alerts from the device and assist with emergency response.
- Hospitals and health care providers — Hospitals and providers who must follow new billing rules for patients who remain in the hospital beyond the point of medical necessity due to lack of appropriate post-acute placement.
- Medicaid-managed care organizations — Medicaid-managed care organizations, which must establish new administrative processes and ensure payment for certain hospital stays and covered devices.
- Children and adolescents — Children and youth up to age 18, who gain access to new or expanded mental health and developmental screenings under the bill’s provisions.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
Coverage of seizure detection devices could significantly reduce injury and death for people with epilepsy, especially those living alone or with limited caregiver support — directly improving safety and quality of life for a high-risk, often underserved population.
Public SafetyPeopleRef: Sec. 1(14)(a)(ii)(A)Mandating coverage for noninvasive colorectal cancer screening and follow-up colonoscopy for Medicaid beneficiaries removes financial barriers to early detection — a proven public health intervention that reduces mortality and long-term treatment costs, especially for low-income and rural residents with lower screening rates.
HealthcarePeopleRef: Sec. 1(12)Expanded mental health screening for youth (12–18), maternal depression, and early childhood assessment using DC:0-5 supports early intervention — critical for improving long-term developmental, academic, and mental health outcomes for vulnerable children and families.
HealthcarePeopleRef: Sec. 1(9), (10), (11)Biennial review and update of FDA-approved seizure detection devices ensures beneficiaries have access to the latest technology — preventing obsolescence and improving equity for people who rely on evolving assistive technologies.
HealthcarePeopleRef: Sec. 1(14)(c)New hospital billing rules for extended stays due to lack of post-acute placement may reduce financial disincentives for hospitals to discharge patients promptly — potentially improving patient flow and reducing unnecessary institutionalization.
HealthcarePeopleRef: Sec. 1(13)(a)
Potential Concerns (5)
Hospitals may face administrative and financial strain from new billing requirements for patients who remain in the hospital beyond medical discharge due to lack of post-acute placement, potentially increasing costs passed to local health systems and counties responsible for long-term care placements.
Local GovernmentRef: Sec. 1(13)(a)Medicaid-managed care organizations (MCOs) must establish new administrative and review processes for hospital stay payments, increasing overhead costs for MCOs — which may reduce funds available for other services or lead to reduced provider reimbursement rates.
Business & EmploymentRef: Sec. 1(13)(e)Mandates are repeatedly tied to ‘subject to appropriation’ or ‘available funds’ language, meaning coverage expansions may not materialize without dedicated funding — creating uncertainty for providers and beneficiaries and potentially leading to underutilization or delayed implementation.
HealthcareLean peopleRef: Sec. 1(9), (10), (11), (12), (13), (14)Reimbursing seizure detection device subscriptions at 100% of the telemonitoring rate may not reflect actual market costs for advanced FDA-approved devices, potentially limiting device access if manufacturers or providers decline to participate due to insufficient reimbursement.
HealthcarePeopleRef: Sec. 1(14)(b)The bill does not address the root cause of hospital “boarder” issues — lack of available long-term care or supported living placements — meaning hospitals will still face delays in discharge despite new billing rules, and individuals needing post-acute care will still face prolonged hospital stays.
HousingRef: Sec. 1(13)(a)(ii)(D)
Who Is Most Affected
People with seizure disorders — especially children, those living alone, or with limited caregiver support — gain direct access to life-saving technology. However, access depends on provider participation and reimbursement adequacy.
Caregivers benefit from alerts and reduced burden, but may face increased responsibility if devices are not user-friendly or if reimbursement delays limit device availability.
Hospitals gain new billing authority for extended stays but face administrative burden and potential revenue uncertainty if MCOs resist payment or if placements remain unavailable.
MCOs must invest in new administrative infrastructure and may face pressure to cover high-cost devices and extended stays — potentially reducing margins or leading to tighter network controls.
Children and youth gain access to critical mental health and developmental screenings, but outcomes depend on availability of trained providers and follow-up services — especially in rural or underserved areas.